228 related articles for article (PubMed ID: 33744931)
1. Onset of comorbidities and flare patterns within pre-existing morbidity clusters in people with gout: 5-year primary care cohort study.
Bajpai R; Muller S; Mallen C; Watson L; Richette P; Hider SL; Roddy E
Rheumatology (Oxford); 2021 Dec; 61(1):407-412. PubMed ID: 33744931
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity clusters in people with gout: an observational cohort study with linked medical record review.
Bevis M; Blagojevic-Bucknall M; Mallen C; Hider S; Roddy E
Rheumatology (Oxford); 2018 Aug; 57(8):1358-1363. PubMed ID: 29672754
[TBL] [Abstract][Full Text] [Related]
3. Frequency and risk factors of gout flares in a large population-based cohort of incident gout.
Rothenbacher D; Primatesta P; Ferreira A; Cea-Soriano L; Rodríguez LA
Rheumatology (Oxford); 2011 May; 50(5):973-81. PubMed ID: 21228059
[TBL] [Abstract][Full Text] [Related]
4. Clustering of gout-related comorbidities and their relationship with gout flares: a data-driven cluster analysis of eight comorbidities.
Liu S; Sun H; Yang S; Liang N; Gao Y; Qu S; Chen H
J Endocrinol Invest; 2024 May; 47(5):1119-1128. PubMed ID: 37906371
[TBL] [Abstract][Full Text] [Related]
5. Cohort study investigating gout flares and management in UK general practice.
Finnikin S; Mallen CD; Roddy E
BMC Prim Care; 2023 Nov; 24(1):246. PubMed ID: 37993770
[TBL] [Abstract][Full Text] [Related]
6. Gout characteristics associate with depression, but not anxiety, in primary care: Baseline findings from a prospective cohort study.
Prior JA; Mallen CD; Chandratre P; Muller S; Richardson J; Roddy E
Joint Bone Spine; 2016 Oct; 83(5):553-8. PubMed ID: 27068619
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 Vaccination and Gout Flare Risk in Patients With Infrequent or Frequent Flares: A Prospective Cohort Study.
He Y; Xue X; Dalbeth N; Terkeltaub R; Chen Y; Yan F; Pang L; Li X; Yuan X; Cheng X; Li C; Sun M
Arthritis Care Res (Hoboken); 2024 Jan; 76(1):131-139. PubMed ID: 37553607
[TBL] [Abstract][Full Text] [Related]
8. Serum Urate and Recurrent Gout.
McCormick N; Yokose C; Challener GJ; Joshi AD; Tanikella S; Choi HK
JAMA; 2024 Feb; 331(5):417-424. PubMed ID: 38319333
[TBL] [Abstract][Full Text] [Related]
9. Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population.
Primatesta P; Plana E; Rothenbacher D
BMC Musculoskelet Disord; 2011 May; 12():103. PubMed ID: 21599917
[TBL] [Abstract][Full Text] [Related]
10. The absolute risk of gout by clusters of gout-associated comorbidities and lifestyle factors-30 years follow-up of the Malmö Preventive Project.
Fatima T; Nilsson PM; Turesson C; Dehlin M; Dalbeth N; Jacobsson LTH; Kapetanovic MC
Arthritis Res Ther; 2020 Oct; 22(1):244. PubMed ID: 33066806
[TBL] [Abstract][Full Text] [Related]
11. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005.
Annemans L; Spaepen E; Gaskin M; Bonnemaire M; Malier V; Gilbert T; Nuki G
Ann Rheum Dis; 2008 Jul; 67(7):960-6. PubMed ID: 17981913
[TBL] [Abstract][Full Text] [Related]
12. Latent Class Growth Analysis of Gout Flare Trajectories: A Three-Year Prospective Cohort Study in Primary Care.
Watson L; Belcher J; Nicholls E; Muller S; Mallen C; Roddy E
Arthritis Rheumatol; 2020 Nov; 72(11):1928-1935. PubMed ID: 32767502
[TBL] [Abstract][Full Text] [Related]
13. Gout Flare Burden, Diagnosis, and Management: Navigating Care in Older Patients with Comorbidity.
Kumar M; Manley N; Mikuls TR
Drugs Aging; 2021 Jul; 38(7):545-557. PubMed ID: 34105100
[TBL] [Abstract][Full Text] [Related]
14. Contemporary epidemiology of gout in the UK general population.
Cea Soriano L; Rothenbacher D; Choi HK; García Rodríguez LA
Arthritis Res Ther; 2011 Mar; 13(2):R39. PubMed ID: 21371293
[TBL] [Abstract][Full Text] [Related]
15. Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout.
Cipolletta E; Tata LJ; Nakafero G; Avery AJ; Mamas MA; Abhishek A
JAMA; 2022 Aug; 328(5):440-450. PubMed ID: 35916846
[TBL] [Abstract][Full Text] [Related]
16. Risk of gout flares after COVID-19 vaccination: A case-crossover study.
Li H; Dalbeth N; Wallace ZS; Sparks JA; Li X; Zeng C; Wang Y; Xie D; Lei G; Wei J; Zhang Y
Semin Arthritis Rheum; 2022 Oct; 56():152059. PubMed ID: 35797765
[TBL] [Abstract][Full Text] [Related]
17. Physical activity measured using wearable activity tracking devices associated with gout flares.
Elmagboul N; Coburn BW; Foster J; Mudano A; Melnick J; Bergman D; Yang S; Chen L; Filby C; Mikuls TR; Curtis JR; Saag K
Arthritis Res Ther; 2020 Aug; 22(1):181. PubMed ID: 32746893
[TBL] [Abstract][Full Text] [Related]
18. Comorbidities in patients with gout prior to and following diagnosis: case-control study.
Kuo CF; Grainge MJ; Mallen C; Zhang W; Doherty M
Ann Rheum Dis; 2016 Jan; 75(1):210-7. PubMed ID: 25398375
[TBL] [Abstract][Full Text] [Related]
19. Effect of Dietary and Supplemental Omega-3 Polyunsaturated Fatty Acids on Risk of Recurrent Gout Flares.
Zhang M; Zhang Y; Terkeltaub R; Chen C; Neogi T
Arthritis Rheumatol; 2019 Sep; 71(9):1580-1586. PubMed ID: 30908893
[TBL] [Abstract][Full Text] [Related]
20. Risk of gout flares after vaccination: a prospective case cross-over study.
Yokose C; McCormick N; Chen C; Neogi T; Chaisson C; Terkeltaub R; Hunter DJ; Zhang Y; Choi H
Ann Rheum Dis; 2019 Nov; 78(11):1601-1604. PubMed ID: 31366470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
